IL13 and chronic kidney disease: Moreover, the sustained release of inflammation-associated fibrotic cytokines such as transforming growth factor-β (TGF-β) and interleukin-13 (IL-13) can trigger epithelial–mesenchymal transition (EMT), potentially leading to renal fibrosis and chronic renal insufficiency [90].